🇺🇸 FDA
Pipeline program

[203Pb]VMT01

VMT01-T101

Phase 2 small_molecule active

Quick answer

[203Pb]VMT01 for Recurrent Melanoma (Skin) is a Phase 2 program (small_molecule) at Perspective Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Perspective Therapeutics
Indication
Recurrent Melanoma (Skin)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials